Another important milestone achieved! Our declaration of conformity as per IVDR, for the PEBBLE qcLAMP Platform, was today approved by the Greek Organization for Medicines! We are one of the first companies in Greece to achieve the IVDR compliance for one of its products!
Congratulations to all the BIOPIXers whose hard work and dedication led to this achievement!!!
BIOPIX DNA TECHNOLOGY P.C. (https://biopix-t.com) was founded in December 2019 in order to commercialize a novel molecular diagnostic method, developed by the founding team, for the detection of nucleic acids at the point-of-care.
The company targets two healthcare-diagnostics related markets through the production of standardized assays for detection and monitoring of Infectious Diseases and Companion Diagnostics.